Shiron Lee

Chief Executive Officer and Co-Founder

Shiron graduated from University of Toronto with an MSc in Pharmaceutical Sciences. Since her master’s studies, she has gained years of experience in gene therapy research for various neurological disorders, both in academia and industry.